Clinical trials
Schizophrenia Patients clinical trials
Below are recruiting schizophrenia patients clinical trials, each written for real people, not researchers. We’re tracking 57 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06504290RecruitingPhase 1
Safety study of VV119 for healthy adults and people with schizophrenia
This trial tests if a new drug called VV119 is safe and how it works in the body. It is for healthy volunteers and for people who have had schizophrenia for at least a year and are currently having worsening symptoms.
Beijing, Beijing MunicipalityAges 18–65 - NCT05349513Recruiting
Testing a home-care program for schizophrenia-like disorders
This study tests a specific kind of care delivered in a home-like setting for people with schizophrenia or schizoaffective disorder. It may help the care team understand what kinds of supports work best and improve day-to-day treatment.
PoitiersAges 18–65 - NCT07192042Recruiting
Testing a device to check sleep breathing in schizophrenia
This trial uses a non-wearable device to assess sleep-disordered breathing in people with schizophrenia who are hospitalized. It aims to understand if this easy method can help monitor sleep issues.
New Taipei CityAges 20–70 - NCT05671185Recruiting
Brain stimulation for schizophrenia symptoms and depression
This study tests repeated brain stimulation (rTMS) to see if it can improve symptoms of schizophrenia and related depression, and measure body/brain changes. You may be considered if you have schizophrenia or schizoaffective disorder with enough depressive symptoms, and if recent treatments and medical safety factors fit the rules.
Douliu, YunlinAges 20 years+ - NCT07045142RecruitingPhase 3
Metformin for blood sugar issues from statins in schizophrenia
This trial tests whether metformin can help prevent or manage blood sugar problems that may arise when people with schizophrenia take statins (cholesterol-lowering drugs). If you have schizophrenia, are on a stable medication routine, and have high cholesterol but not diabetes, this study might be an option.
Zhumadian, HenanAges 18–65 - NCT07557381Recruiting
Game-Based Brain Training for Schizophrenia
This study tests whether playing games on a smartphone or tablet can help improve memory, attention, and thinking skills in people with schizophrenia. Researchers will track how the game-based training affects cognitive abilities over time.
ShanghaiAges 18–45 - NCT07173192Enrolling by invitation
Empowerment program for schizophrenia caregivers
This trial tests a program designed to support relatives who care for someone with schizophrenia. It aims to help caregivers feel more confident and capable.
Istanbul, CevizlibağAges 18–65 - NCT06740747Recruiting
Brain stimulation for schizophrenia symptoms
This study tests a new type of brain stimulation (called intermittent theta-burst stimulation) to see if it helps with symptoms like lack of motivation or trouble thinking clearly in people with schizophrenia. You will also have an MRI scan to see how the brain changes.
Hanover, Lower SaxonyAges 18–65 - NCT06562504Recruiting
Study of temporal memory in people with schizophrenia
This study looks at how people with schizophrenia process time-related memories. Researchers will test your memory using tasks on a computer to better understand how the brain works.
Lanzhou, GansuAges 18–50 - NCT04871048Recruiting
tDCS training to reduce cannabis use in people with schizophrenia
This trial tests whether a non-painful brain stimulation method (tDCS) can help people with schizophrenia who also have moderate-to-severe cannabis use disorder reduce or quit cannabis. It also involves MRI scanning to help study brain changes.
BronAges 18–60 - NCT05159349Recruiting
Studying mental health support for adults with schizophrenia
This trial is studying mental health across the daily life of people living in the community who have schizophrenia. It may help by improving how care is planned and supported over time for people living in Shanghai.
ShanghaiAges 18–65 - NCT05435300Recruiting
tDCS study using brain scans in schizophrenia
This trial tests whether a non-invasive brain stimulation approach (tDCS) changes brain connections in people with schizophrenia. It also uses specialized scans to look for changes in the brain that could help explain how treatment works.
Toronto, OntarioAges 18 years+ - NCT06174116RecruitingPhase 4
Adding lumateperone to clozapine for schizophrenia
This trial tests whether adding lumateperone, an antipsychotic medication, to clozapine can improve metabolic health in people with schizophrenia. It aims to see if this combination helps with weight, blood sugar, and cholesterol levels.
Worcester, MassachusettsAges 18–65 - NCT06470516Recruiting
Brain stimulation for cognitive issues in schizophrenia
This study tests a type of brain stimulation called high-definition transcranial alternating current stimulation (hi-tACS) to see if it can improve thinking and memory in people with schizophrenia. If you are a right-handed adult with stable schizophrenia, you may be able to join.
Hanzhou, ZhejiangAges 18 years+ - NCT06502964RecruitingPhase 2
ALTO-101 study for schizophrenia cognitive symptoms
This study tests an experimental medication called ALTO-101 for people with schizophrenia who also have cognitive impairment (memory or thinking problems). It aims to see if the drug can improve these symptoms while you continue your current antipsychotic treatment.
Garden Grove, CaliforniaAges 21–55 - NCT06617104Recruiting
Nervous system and energy study for schizophrenia
This study looks at how the nervous system and energy pathways in your body work in people with schizophrenia. It aims to find differences that could help improve future treatments.
TaipeiAges 18–65 - NCT06821945RecruitingPhase 2
Olanzapine dosing study for schizophrenia
This trial tests a slower, lower-dose schedule of the drug olanzapine for people with schizophrenia. It aims to see if a gentler start is safer and works as well, especially for those who may need less medication due to other health conditions.
DaeguAges 19 years+ - NCT06961968RecruitingPhase 3
Schizophrenia medication withdrawal study
This study tests whether patients with schizophrenia can safely stop or reduce their current medication without worsening symptoms. It is designed for people who need ongoing psychiatric care.
Rogers, ArkansasAges 18–65 - NCT02640911Recruiting
Long-term study of certain antipsychines in schizophrenia
This is an observational (non-intervention) study that follows adults with schizophrenia who are taking specific “atypical” antipsychotic medicines long-term. Researchers want to learn about patients’ experiences and outcomes while on these treatments.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07493551Recruiting
Bioequivalence study of a long-acting injection for schizophrenia
This trial tests whether a new version of an extended-release injection is as effective as the original in people with schizophrenia. The study helps ensure patients have access to a reliable treatment option.
Beijing, Beijing MunicipalityAges 18–65 - NCT07225712RecruitingPhase 3
Long-term study of an experimental drug for stable schizophrenia
This trial tests a new medication called SEP-363856 over a long period for people with schizophrenia who are currently stable. It looks at how well the drug works and its safety over time.
FukuokaAges 18 years+ - NCT07074704Enrolling by invitation
Brain stimulation to improve symptoms and thinking in schizophrenia
This study tests whether a gentle electrical current applied to the scalp (transcranial alternating current stimulation, or tACS) can help reduce negative symptoms and improve thinking in people with long-term schizophrenia. It is for patients who have been hospitalized for over six months and are on stable medication.
Shanghai, Shanghai MunicipalityAges 18–65 - NCT04629352Recruiting
tDCS brain-stimulation for hearing voices in schizophrenia
This study tests whether a non-invasive brain-stimulation treatment (tDCS) can improve response to care in people who experience clinically significant hearing voices. It may help by changing brain activity, aiming to reduce or improve auditory hallucinations.
Bengaluru, KarnatakaAges 18–45 - NCT05956951Recruiting
Auditory stimulation for early schizophrenia brain efficiency
This study tests whether special sound-based stimulation can help improve brain “communication timing” in people with early-course schizophrenia. It compares participants with early-course schizophrenia to healthy volunteers without a psychiatric history to see how brain function changes.
Pittsburgh, PennsylvaniaAges 18–40
Hear when a new Schizophrenia Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for schizophrenia patients?
- Yes. Clin2 currently lists 57 recruiting schizophrenia patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a schizophrenia patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a schizophrenia patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.